MacroGenics
MGNX
#9389
Rank
โ‚น7.86 B
Marketcap
โ‚น124.33
Share price
-2.14%
Change (1 day)
-54.61%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.54. In 2024 the company made an earnings per share (EPS) of -โ‚น97.10 a decrease over its 2023 EPS that were of -โ‚น13.61.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-94.87%
2024-โ‚น97.10613.33%
2023-โ‚น13.61-92.31%
2022-โ‚น176.96-42.14%
2021-โ‚น305.8336.44%
2020-โ‚น224.15-21.84%
2019-โ‚น286.77-24.58%
2018-โ‚น380.24675.93%
2017-โ‚น49.00-68.05%
2016-โ‚น153.37168.25%
2015-โ‚น57.17-55%
2014-โ‚น127.053400%
2013-โ‚น3.63-108.68%
2012โ‚น41.8324.49%
2011โ‚น33.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-โ‚น160.63 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น156.09-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น689.14-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น591.69-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,182-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,862-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น269.53-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA